OCEANTECH ACQUISITIONS AND CAPTURA BIOPHARMA, INC. ANNOUNCE SIGNING OF DEFINITIVE BUSINESS COMBINATION AGREEMENT

OceanTech Acquisitions, in which Carlson Investments ASI SA (a subsidiary of Carlson Investments SE) holds shares, has entered into an agreement to acquire Captura Biopharma. The boards of both companies expect the deal to be finalized in Q4 2022. 

Upon closing, OceanTech Acquisitions will change its name to Captura Biopharma Holdings Inc. and plans to remain listed on New York’s #NASDAQ where is currently listed. 

The combined company will have a market capitalization of approximately $224.3 million, assuming a share price of $10 and no redemptions reported by existing OceanTech shareholders. This gives a minimum 100% return on investment for Carlson Investments over a 12-month period.

Link: https://www.bloomberg.com/press-releases/2022-08-10/oceantech-acquisitions-i-corp-and-captura-biopharma-inc-announce-signing-of-definitive-business-combination-agreement

PREVIOUS PAGEBACK NEXT PAGENEXT